港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫美概念股

615.910

-2.061-0.33%

漲家數：4

跌家數：9

平家數：- -

市盈率：- -

高：629.455

開：617.017

低：610.131

收：617.971

資料載入中...

復星醫藥控股子公司獲鹽酸替那帕諾片上市許可

復星醫藥(600196.SH)：複方匹可硫酸鈉顆粒上市註冊申請獲批准

復星醫藥(600196.SH)：鹽酸溴己新注射液藥品註冊申請獲受理

復星醫藥(600196.SH)：鹽酸替那帕諾片上市許可申請獲批

【復星醫藥：鹽酸溴己新注射液獲藥品註冊申請受理】復星醫藥公告，控股子公司重慶藥友製藥有限責任公司就鹽酸溴己新注射液的藥品註冊申請於近日獲國家藥品監督管理局受理。鹽酸溴己新注射液為復星醫藥自主研發的化學藥品，擬用於在口服給藥困難的情況下，肺結核、塵肺病、手術後等疾病的祛痰。

復星醫藥02月26日獲主力加倉2369萬元

昊海生物科技02月26日獲主力加倉113萬元

醫思健康盤中異動快速上漲5.63%報0.750港元

復鋭醫療科技盤中異動快速拉昇5.07%報3.940港元

褪去 “新冠概念”的“趕考人”：如何重塑競爭力？

21世纪经济报道

瑞麗醫美盤中異動下午盤大幅上漲6.48%

三生製藥盤中異動快速上漲5.00%報7.140港元

三生製藥(01530)上漲5.0%，報7.14元/股

昊海生物科技盤中異動下午盤快速上漲5.15%報27.550港元

四環醫藥盤中異動股價大漲5.08%

復星醫藥獲控股股東復星高科技質押3000萬股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1593/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":615.91016,"timestamp":1741334919528,"preClose":617.97076,"halted":0,"volume":98237105,"delay":0,"changeRate":-0.003334,"change":-2.060608,"pbRate":1.190795,"amount":537677282,"amplitude":0.031271,"prevYearClose":571.87146,"fiveDayClose":612.07,"twentyDayClose":570.981,"turnoverRate":0.004789,"marketCap":111057548872,"floatMarketCap":73073330248,"peRate":21.56404},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":629.45526,"amplitude":0.031271,"preClose":617.97076,"low":610.1307,"pbRate":"1.190795","latestPrice":615.91016,"volume":98237105,"delay":0,"open":617.01715,"prevYearClose":571.87146,"prevWeekClose":612.07,"prevMonthClose":612.07,"prevQuarterClose":571.871,"fiveDayClose":612.07,"twentyDayClose":570.981,"sixtyDayClose":575.728,"secType":"PLATE","market":"HK","turnoverRate":0.004789,"peRate":21.56404,"marketCap":111057548872,"floatMarketCap":73073330248,"timestamp":1741334919528,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":4,"down":9,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:16,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514883000","title":"復星醫藥控股子公司獲鹽酸替那帕諾片上市許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2514883000","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514883000?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 16:44","pubTimestamp":1740559447,"startTime":"0","endTime":"0","summary":"2月26日，复星医药（600196/02196）发布公告，控股子公司复星医药产业获得盐酸替那帕诺片的上市许可，该药品用于控制慢性肾脏病（CKD）成人透析患者的血清磷水平。该药品的上市许可申请已于近日获得国家药品监督管理局批准，适应症为对磷结合剂疗效不充分或不耐受的患者。截至2025年1月，集团针对该药品的累计研发投入约为1.8亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502263330330856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1593","BK1515","02196"],"gpt_icon":0},{"id":"2514883180","title":"復星醫藥(600196.SH)：複方匹可硫酸鈉顆粒上市註冊申請獲批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2514883180","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514883180?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 16:34","pubTimestamp":1740558851,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(600196.SH)发布公告，公司控股子公司苏州二叶制药有限公司就复方匹可硫酸钠颗粒的上市注册申请于近日获国家药品监督管理局批准。该药品主要用于结肠镜检查、X射线检查前的肠道清洁准备，用于必要时在外科手术前清洁肠道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK0188","BK1515","BK0196","BK0187","BK0012","BK0060","BK0183","BK0239","BK1191","600196","02196","BK0175","BK0028","BK1593"],"gpt_icon":0},{"id":"2514839448","title":"復星醫藥(600196.SH)：鹽酸溴己新注射液藥品註冊申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2514839448","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514839448?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 16:31","pubTimestamp":1740558706,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(600196.SH)发布公告，公司控股子公司重庆药友制药有限责任公司就盐酸溴己新注射液的药品注册申请于近日获国家药品监督管理局受理。该药品拟用于在口服给药困难的情况下，以下疾病和症状的祛痰：肺结核、尘肺病、手术后。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK0196","02196","BK1515","600196","BK0188","BK0012","BK0239","BK0060","BK0187","BK0175","BK0028","BK0096","BK1191","BK0183"],"gpt_icon":0},{"id":"2514883548","title":"復星醫藥(600196.SH)：鹽酸替那帕諾片上市許可申請獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2514883548","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514883548?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 16:28","pubTimestamp":1740558531,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(600196.SH)发布公告，公司控股子公司上海复星医药产业发展有限公司(简称“复星医药产业”)获许可产品盐酸替那帕诺片(中国境内1商品名：万缇乐®)的上市许可申请于近日获国家药品监督管理局批准，本次获批适应症为用于控制对磷结合剂疗效不充分或不耐受的慢性肾脏病(CKD)成人透析患者的血清磷水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK1191","BK0096","BK0183","BK0239","BK1593","BK0012","BK0187","BK1515","BK0060","600196","02196","BK0175","BK0028","BK0196"],"gpt_icon":0},{"id":"2514844883","title":"【復星醫藥：鹽酸溴己新注射液獲藥品註冊申請受理】復星醫藥公告，控股子公司重慶藥友製藥有限責任公司就鹽酸溴己新注射液的藥品註冊申請於近日獲國家藥品監督管理局受理。鹽酸溴己新注射液為復星醫藥自主研發的化學藥品，擬用於在口服給藥困難的情況下，肺結核、塵肺病、手術後等疾病的祛痰。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514844883","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514844883?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 16:26","pubTimestamp":1740558396,"startTime":"0","endTime":"0","summary":"复星医药公告，控股子公司重庆药友制药有限责任公司就盐酸溴己新注射液的药品注册申请于近日获国家药品监督管理局受理。盐酸溴己新注射液为复星医药自主研发的化学药品，拟用于在口服给药困难的情况下，肺结核、尘肺病、手术后等疾病的祛痰。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26162648401364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0187","BK0012","BK0188","BK0028","BK0239","BK1593","600196","BK0196","BK1515","BK1191","02196","BK0096","BK1574","BK0175","01477","BK0060","BK0183"],"gpt_icon":0},{"id":"2514886062","title":"復星醫藥02月26日獲主力加倉2369萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886062","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514886062?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 16:17","pubTimestamp":1740557844,"startTime":"0","endTime":"0","summary":"02月26日, 复星医药股价涨2.81%，报收16.08元，成交金额1.55亿元，换手率1.79%，振幅3.58%，量比1.47。复星医药今日主力资金净流入2369万元，上一交易日主力净流入264万元。该股近5个交易日上涨3.08%，主力资金累计净流入2683万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1654万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226165126abdd945f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226165126abdd945f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1191","BK1515","02196"],"gpt_icon":0},{"id":"2514192886","title":"昊海生物科技02月26日獲主力加倉113萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514192886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514192886?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 16:15","pubTimestamp":1740557743,"startTime":"0","endTime":"0","summary":"02月26日, 昊海生物科技股价涨5.92%，报收27.75元，成交金额1674万元，换手率1.57%，振幅7.06%，量比1.77。昊海生物科技今日主力资金净流入113万元，上一交易日主力净流入17万元。该股近5个交易日上涨7.13%，主力资金累计净流入4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出477万元，其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226164853abdd9381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226164853abdd9381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06826","BK1593"],"gpt_icon":0},{"id":"2514800445","title":"醫思健康盤中異動 快速上漲5.63%報0.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514800445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514800445?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 15:22","pubTimestamp":1740554523,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘15时22分，医思健康股票出现波动，股价急速拉升5.63%。截至发稿，该股报0.750港元/股，成交量99.3万股，换手率0.08%，振幅5.63%。资金方面，该股资金流入60.483万港元，流出9.546万港元。医思健康股票所在的医疗及医学美容服务行业中，整体涨幅为0.41%。其相关个股中，瑞丽医美、固生堂、雍禾医疗涨幅较大，振幅较大的相关个股有雍禾医疗、瑞丽医美、美中嘉和，振幅分别为10.34%、10.19%、8.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261522039893369c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261522039893369c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1215","BK1511","02138"],"gpt_icon":0},{"id":"2514001550","title":"復鋭醫療科技盤中異動 快速拉昇5.07%報3.940港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514001550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514001550?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 15:12","pubTimestamp":1740553969,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘15时12分，复锐医疗科技股票出现异动，股价大幅上涨5.07%。截至发稿，该股报3.940港元/股，成交量204.983万股，换手率0.44%，振幅6.13%。资金方面，该股资金流入552.968万港元，流出191.702万港元。最近的财报数据显示，该股实现营业收入13.18亿港元，净利润8,552.04万港元，每股收益0.18港元，毛利8.22亿港元，市盈率7.50倍。复锐医疗科技股票所在的医疗设备及用品行业中，整体涨幅为0.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226151249a25477c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226151249a25477c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1585","01696","BK1100"],"gpt_icon":0},{"id":"2514100976","title":"褪去 “新冠概念”的“趕考人”：如何重塑競爭力？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514100976","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514100976?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 14:41","pubTimestamp":1740552060,"startTime":"0","endTime":"0","summary":"　　2025年开年尚不足两个月，已至少有9家生物医药领域的公司向港交所递交了IPO招股书。其中不乏迈威生物、恒瑞医药和百利天恒三家已在A股上市的药企冲刺港股。　　而作为此前“新冠概念”中的明星药企，旺山旺水和真实生物先后赴港上市也备受关注。这也是真实生物继2022年递表失效后，再次申请港股上市。　　事实上，新冠疫情期间，新冠产品的市场竞争也已近乎白热化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-02-26/doc-inemuvpf0426222.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-02-26/doc-inemuvpf0426222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0405327148.USD","LU1969619763.USD","02196","LU0170899867.USD","LU1064131003.USD","688062","BK4548","BK0060","BK1191","BK4551","BK1593","BK4588","LU2148510915.USD","LU0405327494.USD","BK4208","LU1064130708.USD","LU2328871848.SGD","BK0183","BK0012","BK0188","BNTX","BK4139","BK0196","ED","BK4568","BK0239","LU2346227817.USD","600276","BK4535","LU1328615791.USD","BK0028","688506","BK4585","LU2488822045.USD","BK1515"],"gpt_icon":0},{"id":"2514005483","title":"瑞麗醫美盤中異動 下午盤大幅上漲6.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514005483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514005483?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 14:37","pubTimestamp":1740551869,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘14时37分，瑞丽医美股票出现异动，股价大幅上涨6.48%。截至发稿，该股报0.115港元/股，成交量53.8万股，换手率0.10%，振幅10.19%。瑞丽医美股票所在的医疗及医学美容服务行业中，整体涨幅为0.27%。其相关个股中，瑞丽医美、固生堂、雍禾医疗涨幅较大，振幅较大的相关个股有雍禾医疗、瑞丽医美、美中嘉和，振幅分别为10.34%、10.19%、8.01%。瑞丽医美公司简介：瑞丽医美国际控股有限公司是一家主要从事提供医疗美容服务的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261437499893299a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261437499893299a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","02135","BK1209"],"gpt_icon":0},{"id":"2514500897","title":"三生製藥盤中異動 快速上漲5.00%報7.140港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514500897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514500897?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 13:53","pubTimestamp":1740549194,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘13时53分，三生制药股票出现波动，股价急速拉升5.00%。截至发稿，该股报7.140港元/股，成交量1437.75万股，换手率0.60%，振幅6.18%。资金方面，该股资金流入6084.78万港元，流出2286.93万港元。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。三生制药股票所在的药品行业中，整体涨幅为0.50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261353159630c12f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261353159630c12f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01530","BK1593","BK1583"],"gpt_icon":0},{"id":"2514008651","title":"三生製藥(01530)上漲5.0%，報7.14元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514008651","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514008651?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 13:53","pubTimestamp":1740549193,"startTime":"0","endTime":"0","summary":"2月26日，三生制药(01530)盘中上涨5.0%，截至13:53，报7.14元/股，成交1.0亿元。三生制药是一家主要致力于开发、生产和销售医药产品，产品包括重组人血小板生成素、肿瘤坏死因子α抑制剂以及重组人促红素等，销售市场涵盖国内以及斯里兰卡、多米尼加共和国和泰国等海外市场。此外，公司通过其子公司集思有限公司,香港三生医疗有限公司和沈阳三生制药有限责任公司也从事项目管理和咨询业务。截至2024年中报，三生制药营业总收入43.89亿元、净利润10.9亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/26135348396180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1593","BK1161","01530","BK1583"],"gpt_icon":0},{"id":"2514900811","title":"昊海生物科技盤中異動 下午盤快速上漲5.15%報27.550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514900811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514900811?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 13:51","pubTimestamp":1740549063,"startTime":"0","endTime":"0","summary":"2025年02月26日下午盘13时51分，昊海生物科技股票出现异动，股价急速上涨5.15%。截至发稿，该股报27.550港元/股，成交量38.252万股，换手率0.98%，振幅5.73%。资金方面，该股资金流入484.368万港元，流出319.737万港元。昊海生物科技股票所在的医疗设备及用品行业中，整体涨幅为0.13%。其相关个股中，先健科技、昊海生物科技、爱康医疗涨幅较大，振幅较大的相关个股有润迈德-B、堃博医疗-B、微创机器人-B，振幅分别为21.92%、9.09%、8.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261351039630c09c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261351039630c09c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06826","BK1593","BK1161"],"gpt_icon":0},{"id":"2514637020","title":"四環醫藥盤中異動 股價大漲5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514637020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514637020?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 09:48","pubTimestamp":1740534480,"startTime":"0","endTime":"0","summary":"2025年02月26日早盘09时48分，四环医药股票出现波动，股价快速拉升5.08%。四环医药股票所在的药品行业中，整体涨幅为0.01%。其相关个股中，华控康泰、三爱健康集团、德琪医药-B涨幅较大，振幅较大的相关个股有德琪医药-B、李氏大药厂、和黄医药，振幅分别为6.76%、4.03%、3.83%。最新业绩公告指出，2024年公司医美板块收入增速保持不低于50%。自Sylfirm X双波射频获批上市后，品牌影响力持续扩大。紧接着在2月11日，四环宣布以572万港元回购1000万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226094800abdd19f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226094800abdd19f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","00460","BK1593","BK1600"],"gpt_icon":0},{"id":"2514021635","title":"復星醫藥獲控股股東復星高科技質押3000萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2514021635","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514021635?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 08:46","pubTimestamp":1740530760,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　复星医药（02196）发布公告，公司于2025年2月25日接到控股股东上海复星高科技（集团）有限公司（简称“复星高科技”）的通知，其已将所持有公司的部分A股股份办理质押手续，本次质押股份数量为3000万股。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-26/doc-inemukxr9084502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600196","BK0012","BK0096","BK0183","BK1191","BK0188","BK0060","BK1593","BK0196","02196","BK0239","BK1515","BK0028","BK0187","BK0175"],"gpt_icon":0}],"pageSize":16,"totalPage":9,"pageCount":7,"totalSize":131}]}}